ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,308.15
1.17%
US Tech 100
18,150.80
0.19%
다우존스 지수
39,908.00
0.88%
Bitcoin
66,199.98
-0.09%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Verona Pharma Plc (VRNA)

  7. Verona Pharma Plc (VRNA) 뉴스

VRNA Verona Pharma Plc

13.95
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:09:55
15분 지연
기업명 주식 심볼 시장 주식 타입
Verona Pharma Plc VRNA 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 13.95 17:09:55
개장가 저가 고가 종가 전일 종가
13.95
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
10/05/202422:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/05/202421:53EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/05/202420:22EDGAR2Form 8-K - Current report
09/05/202420:18EDGAR2Form 8-K - Current report
09/05/202420:15GLOBEVerona Pharma Reports First Quarter 2024 Financial Results..
09/05/202420:00GLOBEVerona Pharma Announces $650 Million Strategic..
02/05/202415:00GLOBEVerona Pharma to Present Additional Analyses of Positive..
25/04/202415:00GLOBEVerona Pharma to Report First Quarter 2024 Financial Results..
09/03/202406:18EDGAR2Form PRE 14A - Other preliminary proxy statements
08/03/202411:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/03/202416:00GLOBEAndrew Fisher Joins Verona Pharma as General Counsel
29/02/202423:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/02/202420:08EDGAR2Form 8-K - Current report
29/02/202416:00GLOBEVerona Pharma Reports Fourth Quarter and Full Year 2023..
15/02/202416:00GLOBEVerona Pharma to Report Fourth Quarter and Full Year 2023..
06/02/202408:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202406:19EDGAR2Form 144 - Report of proposed sale of securities
02/02/202420:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/02/202420:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/02/202420:02EDGAR2Form 8-K - Current report
01/02/202416:00GLOBEMichael Austwick Joins Verona Pharma as Non-Executive..
03/01/202416:00GLOBEVerona Pharma to Present at 42nd Annual J.P. Morgan..
02/01/202420:02EDGAR2Form 8-K - Current report
02/01/202416:00GLOBEVerona Pharma enters into Debt Facility of up to $400..
19/12/202306:15EDGAR2Form 8-K - Current report
17/11/202316:00GLOBEVerona Pharma’s President and CEO David Zaccardelli Wins..
08/11/202316:00GLOBEVerona Pharma Announces November 2023 Investor Conference..
04/11/202309:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202309:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202305:25EDGAR2Form 144 - Report of proposed sale of securities
03/11/202305:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202319:24EDGAR2Form 8-K - Current report
02/11/202316:04GLOBEVerona Pharma Reports Third Quarter 2023 Financial Results..
25/10/202305:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202305:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202315:00GLOBEVerona Pharma to Report Third Quarter 2023 Financial Results..
06/10/202315:00GLOBEVerona Pharma to Host Investor Update on Commercialization..
03/10/202315:00GLOBEVerona Pharma to Present Additional Analyses of Positive..
11/09/202319:02EDGAR2Form 8-K - Current report
11/09/202315:00GLOBEVerona Pharma Announces the US FDA has Accepted the New Drug..
06/09/202315:00GLOBEVerona Pharma to Present Additional Analysis of Phase 3..
06/09/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202305:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/09/202305:05EDGAR2Form 8-K - Current report
31/08/202315:00GLOBEChristina Ackermann Joins Verona Pharma as Non-Executive..
08/08/202310:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/08/202310:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/08/202309:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/08/202309:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
VRNA
Verona Pharma
NYSE
OXY
Occidental Petroleum
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유